Charles River Laboratories
Dr. Ho returned to Charles River in 2012 as Corporate Senior Vice President, Corporate Strategy and Chief Strategy Officer, after previously serving as the Company’s Corporate Senior Vice President, Corporate Strategy from 2006 to 2010. Prior to rejoining Charles River, Dr. Ho was President of Decision Resources Consulting.
Dr. Ho has more than 20 years of experience serving pharmaceutical, biotech, medical device and provider organizations in a variety of capacities including corporate and M&A strategy formulation, product commercialization, investment decision making, process reengineering and organizational redesign. He was previously a partner at Accenture in its Health and Life Sciences Practice where he led the Discovery and Early Development practice areas. Prior to joining Accenture, Dr. Ho spent five years as a partner in the Life Science Industry Group of Pittiglio Rabin Todd & McGrath, and eight years at McKinsey and Company.
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.